Q Therapeutics

Q Therapeutics is a development stage company based in Salt Lake City, Utah, focused on creating human cell-based therapies for degenerative diseases affecting the brain and spinal cord. The company is primarily engaged in the development of Q-Cells, a novel stem cell therapy designed to treat a range of conditions, including amyotrophic lateral sclerosis (ALS), multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson's disease. Additionally, Q Therapeutics aims to address other neurological disorders such as Alzheimer’s disease, traumatic brain injury, cerebral palsy, leukodystrophies, central nervous system storage diseases, and peripheral neuropathies. The therapies developed by Q Therapeutics work by replacing the insulating myelin on damaged neurons and providing trophic support to restore and preserve normal neurological functions.

Steven Borst

CEO, President and Chairman of the Board of Directors

1 past transactions

Degania Medical

Acquisition in 2016
Degania Medical, founded in 1984, is a technology-focused company specializing in producing silicone medical devices. Its primary business involves manufacturing in-dwelling medical catheters, including cardiovascular catheters, acquired through a French company in 2010. Degania Medical offers comprehensive outsourcing services and supplies silicone medical disposables to hospitals via distributors. The company excels in custom-made production using silicone raw material, providing a full range of services such as product development, engineering design, extrusion, molding, tool & die making, assembly, packaging, private labeling, and sterilization. All products are manufactured under stringent US FDA standards and European CE regulations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.